Education
About Us
Working with TipRanks
Follow Us
Hannah Valantine Insider Profile
4 Followers
Hannah Valantine, Director at Pacific Biosciences, holds 7.86K shares in BridgeBio Pharma (Ticker: BBIO), holds 38.99K shares in CareDx (Ticker: CDNA), holds 22.82K shares in Pacific Biosciences (Ticker: PACB). Most recently, Hannah Valantine Sold ― shares of BridgeBio Pharma on Jun 30, 2025 for an estimated value of 207.32K.
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-24.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Hannah Valantine holds in companies
Most Profitable Insider Trade
The most profitable trade made by Hannah Valantine
Hannah Valantine's Trading History
Pacific Biosciences
Jun 20, 2024
Director
Uninformative Buy
―
$28.75K
CareDx
Jun 23, 2025
Director
Uninformative Sell
202.52K
$470.66K
BridgeBio Pharma
Jun 30, 2025
Director
Informative Sell
207.32K
$361.30K
List of latest transactions for each holding click on a transaction to see Hannah Valantine's performance on stock
You May Also Like
Hannah Valantine insider profile FAQ
What is the percentage of profitable transactions made by Hannah Valantine?
The percentage of profitable transactions made by Hannah Valantine is 0%.
What is the average return per transaction made by Hannah Valantine?
The average return per transaction made by Hannah Valantine is -24.60%.
What stocks does Hannah Valantine hold?
Hannah Valantine holds: PACB, CDNA, BBIO stocks.
What was Hannah Valantine’s latest transaction?
Hannah Valantine latest transaction was an Informative Sell of $207.32K.
What was Hannah Valantine's most profitable transaction?
Hannah Valantine’s most profitable transaction was an Informative Buy of BBIO stock on February 13, 2024. The return on the trade was -5.90%.
What is Hannah Valantine's role in Pacific Biosciences?
Hannah Valantine's role in Pacific Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.